Hardware manufacturer Canaan's landmark U.S. order and Cipher Mining's strategic AI partnerships fuel renewed investor confidence.
Genentech's Tecentriq combination therapy is the first maintenance treatment for extensive-stage small cell lung cancer, a significant advance in a hard-to-treat disease.
Fair Isaac's new direct-to-lender model threatens a core revenue stream for TransUnion and Equifax, sending shares sharply lower.
Company forecasts a $710 million revenue hit from expanded U.S. export restrictions, impacting its significant business in the Chinese market.
The video platform's collaboration with the AI search company aims to enhance content discovery and user experience.
The broad cryptocurrency rally sees XRP top $3 and Ethereum reclaim $4,500 as bullish momentum returns to the market.
Needham reiterates a 'Buy' rating with a $1,950 price target, fueling investor optimism despite significant insider sales.
Broadcom leads the charge as tech giants like Microsoft and Meta pour billions into AI chips, boosting the entire sector.